Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Mead

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
Nature Communications|April 8, 2015
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasmsWilliam Tapper, Amy V Jones, Robert Kralovics, et al.
Blood Advances|November 14, 2022
CNL and aCML should be considered as a single entity based on molecular profiles and outcomesGonzalo Carreño-Tarragona, Alberto Álvarez-Larrán, Claire Harrison, et al.
The New England Journal of Medicine|April 23, 2025
Tumor-Infiltrating Clonal HematopoiesisOriol Pich, Elsa Bernard, Maria Zagorulya, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
Nature Communications|April 8, 2015
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasmsWilliam Tapper, Amy V Jones, Robert Kralovics, et al.
Blood Advances|November 14, 2022
CNL and aCML should be considered as a single entity based on molecular profiles and outcomesGonzalo Carreño-Tarragona, Alberto Álvarez-Larrán, Claire Harrison, et al.
The New England Journal of Medicine|April 23, 2025
Tumor-Infiltrating Clonal HematopoiesisOriol Pich, Elsa Bernard, Maria Zagorulya, et al.
Pageof 13